Vitamin B3 tested as potential new weapon against debilitating migraines

NCT ID NCT05846373

Summary

This study investigated whether adding nicotinic acid (a form of vitamin B3) to a standard migraine prevention medication (a beta-blocker) could better control migraines. For 12 weeks, 58 adults with frequent moderate-to-severe migraines received either a 500mg dose, a 1000mg dose, or a placebo pill in addition to their usual medication. Researchers measured changes in the number of migraine days, headache severity, and quality of life to see if the vitamin supplement provided extra benefit.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE PROPHYLAXIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • BSMMU

    Dhaka, 1000, Bangladesh

Conditions

Explore the condition pages connected to this study.